The cellular retinoic acid binding proteins I and II (CRABPI and CRA-BPU) bind retinoc acid with high affMnity exhibit distinct patterns ofexpression during embryonic devdopment, and are thought to play important roles in the RA signaling pathway. We have generated a targeted mutation of the CRABPI gene using the "hit-and-run" strategy and shown that It prevents the production of a functional CRABPI protein.
Vitamin A is indispensable for vertebrate development and homeostasis. Retinoic acid (RA) administration prevents the appearance of most of the defects induced in vitamin A-deficient animals (for reviews and references, see refs. 1-3). RA excess is teratogenic, which suggests that RA could also play a major role during development (for reviews, see refs. 1 and 3-7) . The RA signal is transduced by two families of nuclear receptors, the RARs and RXRs, which act as ligand-inducible transcriptional regulators (3, (8) (9) (10) (11) . Abnormalities exhibited by fetuses of vitamin A-deprived dams are recapitulated in RAR and/or RXR mouse mutants (ref. 3 ; unpublished results), thus demonstrating the role of RARs and RXRs in the transduction of the RA signal.
In addition, two cytoplasmic RA binding proteins, the cellular retinoic acid binding proteins I and II (CRABPI and CRABPII) are found in all vertebrates that require vitamin A and appear to be highly conserved (4, (12) (13) (14) . Both CRABPI and CRABPII transcripts and proteins are expressed in mouse embryos at all stages of development in distinct, often nonoverlapping patterns (for references, see refs. 7 and 15-17) . This has suggested that CRABPs have essential roles in the retinoid signaling pathway. It has been proposed that CRABPs could spatiotemporally control the level of"free" intracellular RA available for binding to the nuclear receptors: CRABPs may passively sequester RA, functioning as buffers to maintain tolerable concentrations ofintracellular RA, and/or act as modulators of RA catabolism (refs. 18 and 19 ; for reviews, see refs. 4, 7, 13, and 14) . CRABPs may also be involved in the transfer of RA from the cytoplasm to nuclear receptors (20) . Thus CRABPs may play essential roles in the retinoid signaling pathway. To determine these roles, we have initiated studies aimed at generating mutant mice devoid ofeitherCRABPI, CRABPII, or both. We report here that CRABPI null mutant mice appear essentially normal, indicating that CRABPI does not play a crucial role during development and homeostasis.
MATERIALS AND METHODS
Gene Targeting of CRABPI. To construct the hit-and-run (H&R) targeting vector (see Fig. 1A ), a 12-kb HindIII genomic fragment containing the CRABPI gene (21) was subcloned. A 5-nt insertion between the second and third positions of the alanine codon at amino acid position 5 of the CRABPI exon 1 coding region was performed by sitedirected mutagenesis to create a Not I restriction site. The thymidine kinase gene (TK) driven by the GTI-II enhancer (22) was added contiguous to the genomic fragment containing the Not I mutation, and a GTI-GTII enhancer-driven neomycin-resistance gene (22) was inserted adjacent to the TK gene. The resulting CRABPI H&R targeting construct (p775) was linearized at the Spe I site and electroporated into D3 embryonic stem (ES) cells (22, 23) . One G418-resistant ES clone was shown to contain a homologous recombination event ("Hit" reaction) and was further selected with ganciclovir. Surviving ES clones having undergone an intrachromosomal homologous recombination event (H&R reaction, ref. 24) were injected into C57BL/6 blastocysts (22) . Germline transmission was established by mating with C57BL/6 females.
Western Blot Analysis and unohiemiry. Embryos from a CRABPI(H&R) heterozygote intercrossing were removed at 13.5 days postcoitum (dpc). Cytosolic extracts from embryos, whole cell extracts from transfected COS-1 cells, Western blotting, and immunodetection were as described (25) . Rabbit polyclonal antibodies specific for CRABPI and CRABPII were generated (26) using ovalbumincoupled synthetic peptides as antigens [SPB63 (amino acids 95-108) and SPB64 (amino acids 96-109) for mouse CRABPI and CRABPII, respectively]. Histological analysis and in situ hybridization were as described (15, 27) . Immunolocalization of CRABPI was performed using rabbit antibodies raised against two synthetic peptides corresponding to residues 69-84 and 95-107 of bovine CRABPI (28 2) , with pSG5-CRABPI (WT CRABPI, lanes 3-5), or with pSG5-CRABPImut (frameshift-mutated CRABPI, lanes [6] [7] [8] . rv examined RAR mRNA levels in 13.5-dpc, CRABPI(H&R) mutant embryos using probes specific for RARa, RAR(3, and RAR'y isoforms in RNase protection assays (32) . No significant alterations could be detected (data not shown).
The CRABPI(H&R) Disruption Is a Null Mutation. To verify that the engineered frameshift mutation had actually blocked the production of a functional CRABPI, Western blot analyses were performed at 13.5 dpc, when CRABPI is at peak abundance. Although CRABPI could be readily detected in WT and CRABPI(H&R) heterozygotes (CRABPI, Fig. 2B, lanes 2 and 3, top panel) , no CRABPI was detectable under similar conditions in CRABPI(H&R) homozygotes (CRABPI, Fig. 2B, lane 4, top panel; note that the CRABPI polyclonal antibody used here was raised against a C-terminal peptide). In contrast, there was no significant change in CRABPII levels between WT and CRABPI(H&R) heterozygous and homozygous embryos (CRABPII, Fig. 2B,  compare lanes 2-4, bottom panel) . Immunohistochemical analysis was also performed on sections of 10.5-dpc WT and CRABPI(H&R) homozygous embryos using antibodies raised against C-terminal residues of CRABPI (28) . No CRABPI signal could be detected in homozygous mutants (Fig. 3 B, D , and F), whereas it was detectable under similar conditions in various tissues of WT littermate embryos (Fig.  3A, C, andE) .
Since the frameshift mutation is positioned at amino acid 5 of the WT CRABPI (see Fig. 1C ), CRABPI(H&R) mutants might produce undetectable, but phenotypically significant, quantities of an N-terminally truncated CRABPI initiated at methionine position 10 (ref. 33; see Fig. 1C ). Therefore, we engineered an identical frameshift mutation into the CRABPI cDNA of a CRABPI expression vector, pSG5-CRABPI, to create pSG5-CRABPIMUT (data not shown). Transfection of COS-1 cells with pSG5-CRABPI produced CRABPI at levels (per ug of protein) -50-100 times greater than observed in WT embryos (Fig. 2B, lanes 1-5) . pSG5-CRABPIMUT transfected COS-1 cells produced a protein at =1-2% of the level of WT CRABPI in pSG5-CRABPI transfected COS-1 cells (Fig. 2C, compare lanes 5 and 6; data not shown). We conclude that embryos homozygous for the CRABPI (H&R) mutation may produce low amounts (4-2%) of an N-terminally truncated CRABPI.
We next investigated whether the truncated CRABPI could efficiently bind RA. pET-15b-based expression vectors for WT CRABPI and CRABPI deleted for the first 9 amino acid residues [CRABPI(A1-9)] were constructed and the corresponding proteins were produced in E. coli. Western blot analysis showed that 16.5 pg ofprotein of a crude preparation of CRABPI(A1-9) corresponded to -0.5 ug of partially purified recombinant CRABPI (Fig. 4A) (Fig. 4B, lane 4) , whereas no significant binding above background was detected with equivalent or 10-fold higher amounts (as judged from Western blotting) of recombinant CRABPI(A1-9). We conclude that the N-terminally truncated CRABPI(Al-9) (Fig. 4B, lanes 6 and 7) There is no significant difference in the distribution of CRABPI signal in mutant versus control embryo-e.g., in the hindbrain and midbrain epithelium (B and E), the nasal mesenchyme (H and K), or the forelimb distal mesenchyme (N and Q). The CRABPII transcript distribution is not altered in the mutant embryo, even in those regions where CRABPI transcripts are maximally expressed (black areas in bright-field views). AER, apical ectodermal ridge; AO, aorta; DI, distal; DO, dorsal; EP, epithelium; FB, forebrain; FL, forelimb; HB, hindbrain; G, gut; ML, mantle layer; MB, midbrain; ME, mesenchyme; NP, nasal process; OT, otic vesicle; PR, proximal; SC, spinal cord; SG, spinal ganglia; SL, sclerotome; VE, ventral; 4, 5, and 6, rhombomeres; VII/VIII and IX, cranial ganglia. (x 15.) Developmental Biology: Gorry et al. 9036 Developmental Biology: Gorry et al.
unlikely to contain more than 2-4 x 10-4 the amount of functional CRABPI present in WT embryos and therefore that the CRABPI(H&R) mutation can be considered as a null mutation.
In situ hybridization was also used to investigate the relative levels of CRABPII transcripts in 10.5-dpc WT and CRABPI(H&R) homozygous embryos (15) . There was no alteration in the specific expression pattern of CRABPII in the mutants (Fig. 5, compare F , L, and R with C, I, and 0; and data not shown). In particular, there was no increase in CRABPII transcripts in the regions where CRABPI is expressed at a high level relative to CRABPII. Thus, the absence of defects in CRABPI(H&R) mutants cannot be attributed to a compensatory up-regulation of CRABPII expression. Moreover, the expression ofCRABPI transcripts was not altered in CRABPI(H&R) homozygous embryos (Fig. 5, 7, 15 , and 17 and references therein), including the cranio-facial region, the central nervous system, the neural crest derivatives, and the limbs, whose morphogenesis has been postulated to be dependent on a graded expression of CRABPI along the limb antero-posterior axis (7) . It is unlikely that the dispensability of CRABPI corresponds to a functional redundancy with CRABPII, since the pattern of expression of the two genes is often nonoverlapping (15, 16) , and our present data establish that there was no compensatory expression of CRABPII transcripts in regions that normally express CRABPI at high levels. Moreover, the CRAB-P11 content of CRABPI null mutant embryos was similar to that of WT embryos.
Our results exclude the idea that CRABPI could play important role(s) in the homeostatic control of intracellular RA concentration or in the delivery of RA to the RA nuclear receptors, as previously proposed. However, there remains the possibility that CRABPI could be required under conditions of RA excess to prevent teratogenic effects. To investigate this possibility, CRABPI(H&R) null mutant embryos were exposed to excess RA in utero. When RA was administrated to pregnant dams at 8.5 dpc at a low teratogenic dose (10 mg/kg) (34), WT and CRABPI(H&R) heterozygous and homozygous 18.5-dpc mutant fetuses from to the same litters exhibited the same type and incidence of axial skeletal malformations. In addition, there was no increase in the frequency of resorptions of homozygous null embryos (data not shown).
In conclusion, our present study demonstrates that CRABPI cannot be critically involved in any ofits previously postulated functions. However, the construction of CRABPI/CRABPII double mutants is necessary to definitely exclude the possibility of a functional redundancy with CRABPII. The high degree of conservation of CRABPI in vertebrates suggests, nevertheless, that it performs an important function(s) that either cannot be easily detected in the protected environment of animal facilities or confers a low viability advantage (3) .
